GASTROINTESTINAL POLYPOSIS SYNDROMES file• Gingiva proliferation • Vascular malformations •...
Embed Size (px)
Transcript of GASTROINTESTINAL POLYPOSIS SYNDROMES file• Gingiva proliferation • Vascular malformations •...

GASTROINTESTINAL POLYPOSIS SYNDROMES
Stefan Aretz
Institute of Human Genetics
Center for Hereditary Tumour Syndromes
University Hospital Bonn
Germany
Hereditary Cancer Genetics, Lugano, 26.4.2019

DISCLOSURE OF INTEREST
I have no conflict of interest to declare
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

COLORECTAL CANCER (CRC)
SPORADIC, FAMILIAL, HEREDITARY
Lynch syndrome /
HNPCC
Polyposis syndromes
Unknown / unsolved
sporadic
familial
clustering
monogenic 5 %
20-25 %
Other tumour syndromes
(LFS, CMMRD)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

COLORECTAL POLYPS
• 70 years of age: adenoma in ~ 50%
• CRC: ~ 10% of adenomas
• CRC lifetime risk: ~ 6%
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

UNTREATED: HIGH RISK COLORECTAL CANCER (CRC)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

HOW IS A COLORECTAL POLYPOSIS DEFINED?
◆ Adenomatous polyposis:
≥ 10 synchronous adenomas
◆ Juvenile polyposis:
≥ 5 juvenile polyps
◆ Peutz-Jeghers syndrome:
2 PJ polyps
◆ Serrated polyposis:
20-30 serrated polyps
◆ 1°relative with confirmed polyposis
◆ Pathogenic germline mutation
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
GeneReviews: www.ncbi.nlm.nih.gov/gtr/
NCCN: www.nccn.org

GASTROINTESTINAL POLYPOSIS SYNDROMES
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
Familial adenomatous polyposis (FAP)
MUTYH-associated polyposis (MAP)
Peutz-Jeghers syndrome (PJS)
Juvenile polyposis syndrome (JPS)
Cowden / BRR / PHT syndrome (CS)
Serrated polyposis syndrome (SPS)
Cronkhite-Canada syndrome (CCS)
Ganglioneuromatous polyposis
APC
MUTYH
STK11
SMAD4, BMPR1A
PTEN
RNF43, ?
?
RET, PTEN, NF1, ?
Polyposis form Gene
Frequency:
1:10.000 to
< 1:200.000
Polymerase-associated polyposis (PPAP)
Unexplained adenomatous polyposis
POLE, POLD1
?AD
EN
OM
AT
OU
S
HA
MA
RT
O
MA
TO
US
OT
HE
RS
30-90 %
> 90 %
60-80 %
AD
AD
AD
AD
AD
AR
NTHL1-associated polyposis (NAP) NTHL1 AR

DIAGNOSIS
◆ Result endoscopy
◆ Polyp histology
◆ extraintestinal symptoms
◆ Family history
the primary diagnosis of a polyposis syndrome
is based on clinical and histologic findings
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

Polyp Histology
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

MIXTURE OF DIFFERENT POLYP TYPES IS COMMON
Syndrome Polyp histology
Adenomatous polyposis (AP) Serrated / hyperplastic polyps
Peutz-Jeghers syndrome (PJS) Adenomas
Juvenile polyposis syndrome (JPS)Hyperplastic polyps, adenomas,
inflammatory (pseudo-)polyps
Serrated polyposis syndrome (SPS)Hyperplastic-adenomatous polyps,
adenomas
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

EXTRAINTESTINAL MANIFESTATIONS
• Developmental delay
• Bone tumours
• Skin lesions
• Fat tissue tumours
• Pigmentary changes
• Gingiva proliferation
• Vascular malformations
• Macrocephaly
• Disturbed nail development
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

EXTRAINTESTINALE MALIGNANCIES
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

DOMINANT INHERITANCE PATTERN
recurrence risk 50 %
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

RECESSIVE INHERITANCE PATTERN
recurrence risk 25 % for sibs
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

FAMILY HISTORY
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

DIFFERENTIAL DIAGNOSIS ADENOMATOUS POLYPS
Lynch syndrome(MLH1, MSH2, MSH6, PMS2)
MAP(MUTYH)
FAP(APC)?
„mixed“Polyposis
NAP(NTHL1)
PPAP(POLE/D1)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

NON-ADENOMATOUS / HAMARTOMATOUS POLYPS
JPS(SMAD4; BMPR1A)
SPS
CS / PHTS(PTEN)
CCSPJS(STK11)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

OVERLAPPING EXTRAINTESTINAL TUMOUR SPECTRUM
Lynch syndromeMMR genes
(MLH1, MSH2, MSH6, PMS2)
MAP(MUTYH)
Sebaceous gland
Endometrium
Urinary tract
Ovaries
Vogt et al., Gastroenterology 2009
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

HIGH AND LOW PENETRANT GENES
Stoffel et al. Gastroenterology 2018
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

GENETIC GERMLINE DIAGNOSTICS
Adenomatous polyposis
APC, BUB1B, MSH3, MUTYH,
NTHL1, POLD1, POLE
Polyposis, unclear histology
APC, BMPR1A, MSH3, MUTYH,
NTHL1, POLD1, POLE, PTEN,
RNF43, SMAD4, STK11, TP53
Multi gene analysis
(Gene panels)
Hamartomatous polyposis
BMPR1A, PTEN, SMAD4,
STK11, TP53
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

PROCEDERE GENETIC DIAGNOSTICS
46
41 35 53 32
47 39 38
22 17 118
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

DIAGNOSTIC ALGORITHM GI POLYPS
Patient with gastointestinal polyps
Clinical evaluation:
Polyp number, histology, distribution
yes
Clinical
evidence for
polyposis?
Keine weitere Abklärung
erblicher Darmkrebs
no
Suspicious family history:
• Clustering of tumours in
family / relative?
• Unusual early-onset
disease?
• Relative with polyposis?
noGenetic counselling
yes
Genetic diagnostics
pathogenic
mutation
identified?
Genetic counselling
and predictive testung
yes
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
Aretz / Steinke-Lange

CANCER SURVEILLANCE RECOMMENDATIONS
Successful example of individualized medicine
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
Ach
atz
et a
l., C
linC
ance
r R
es 2
01
7

GERMLINE MUTATIONS ADENOMATOUS POLYPOSIS
(2001)
APC
~ 50%?
~ 50%
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

CMMRD
NAPNTHL1
GAPPSIntronic APC
Promoter 1B deletions
PPAPPOLE + POLD1
APC
mosaics
GERMLINE MUTATIONS ADENOMATOUS POLYPOSIS
(2016)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

LOW-LEVEL APC MUTATIONAL MOSAICISM
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

APC MUTATION SCREENING IN MULTIPLE ADENOMAS
Leukocyte
DNA: 0 % mutant reads
(Multiplicom: coverage = 2650)
Adenoma
DNA: 17-92 % mutant reads
Patient 5 – APC:c.4127_4128delAT;p.Tyr1376Cysfs*9
Sanger (reverse)
Leukocyte
Adenoma 1
Adenoma 2
Adenoma 3
Adenoma 4
3 additional
adenomas
Spier et al. JMG 2016
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019

NON APC ADENOMATOUS POLYPOSIS SYNDROMES
Dominant (heterozygous germline mutations)
PPAP = Polymerase Proofreading-associated polyposis (POLE, POLD1)
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
Recessive (biallelic germline mutations)
MAP = MUTYH-associated polyposis (MUTYH)
NAP = NTHL1-associeted polyposis (NTHL1)
MSH3AP = MSH3-associated polyposis (MSH3)
CMMRD = Constitutional Mismatch Repair Deficiency (MSH6, PMS2)
Caused by germline mutations in DNA repair genes
Attenuated course of adenomatous polyposis
Broad extraintestinal tumour spectrum

NTHL1-ASSOCIATED POLYPOSIS
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019
Grolleman et al. , Cancer cell 2019
Using mutational signatures to determine the NTHL1-related tumourspectrum in patients with biallelic germline mutations in NTHL1

POLYPOSIS: SUMMARY AND CONCLUSIONS
• Diagnostics primarily based on endoscopic findings
and histology
• Clinical differential diagnosis often challenging
• Multi-gene / panel testing increasingly important in
routine diagnostics
• Dominant types of hereditary cancer more common
(because easier to identify with previous methods)
• Novel monogenic subtypes identified by exome
sequencing: recessively inherited and caused by
DNA repair genes
• Increased risk of extracolonic tumors, in particular
endometrial cancer
Aretz – Institute of Human Genetics Bonn Gastrointestinal Polyposis Syndromes Lugano, 26.04.2019